表紙
市場調査レポート

中国の体外診断試薬産業の調査と予測

Research and Forecast of China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2014-2018

発行 Huidian Research 商品コード 278310
出版日 ページ情報 英文 90 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
中国の体外診断試薬産業の調査と予測 Research and Forecast of China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2014-2018
出版日: 2014年02月20日 ページ情報: 英文 90 Pages
概要

中国において体外診断試薬産業は歴史も若く、その発展は欧米諸国に後れをとっている状態です。体外診断試薬特別委員会提供のデータによると、国内の関連メーカーは300から400社。そのうち、指定基準以上の規模を有するものは200社に及ぶ一方、年商1億中国元を上回る力を備えた企業はおよそ20社のみ。企業は概ね小規模で取扱品目は小幅です。2013年の時点で国内体外診断市場の全体規模は225億人民元に達し、この中で体外診断試薬が約163億人民元を占めています。

当レポートでは、こうした中国体外診断試薬産業に注目し、その外的環境や市場活動、輸出入、競合状況ほか、さまざまな側面からの最新市場情報をまとめて、概略下記の構成でお届けします。

第1章 体外診断試薬産業の概要

  • 定義と分類
    • 生物学的製剤の定義と分類
    • 体外診断試薬の定義と分類
  • 発展史
  • 産業チェーン
  • 主要分野の概要
    • 生化学診断試薬産業
    • 免疫診断試薬
    • 分子診断試薬

第2章 中国体外診断試薬産業の稼働環境

  • 世界的に見た体外診断試薬産業の発展概況
  • 中国生物医薬品産業の発展概況
  • 関連産業の運営と政策
    • 産業統括官庁
    • 産業指導体制
    • 主な法令および規制
    • 主な産業政策

第3章 中国体外診断試薬市場の稼働状況

  • 発展状況
  • 需要
    • 市場の全体需要
    • 主要品目の発展動向
  • 競合環境
  • 参入障壁
    • 技術の障壁
    • 品質・ブランドの障壁
    • マーケティングチャネルの障壁
    • 市場アクセスの障壁
  • 利益水準と動向変化
  • 産業発展に対する阻害ファクター
    • 低い市場集中率、深刻な製品均一性
    • 相対的に低水準の全般的研究開発投資
    • 外資系大企業による国内高級市場の占有
  • 技術水準とビジネスモデル
    • 技術水準と開発動向
    • ビジネスモデルの特徴
  • 周期性、地域特性、季節性
    • 周期性
    • 地域特性
    • 季節性
  • 体外診断試薬産業への上流・下流産業の関連性と影響

第4章 中国体外診断試薬産業の輸出入

  • 輸入
  • 輸出

第5章 中国体外診断試薬産業の主要企業(企業プロフィール、事業、主たる競争力、研究開発プロジェクトおよび事業計画など)

  • Shanghai Kehua Bio-engineering Co., Ltd.
  • DAAN Gene Co., Ltd.
  • Shanghai Fosun Pharmaceutical (Group) CO., Ltd.
  • BioSino Bio-technology and Science Inc.
  • Beijing Leadman Biochemistry Co., Ltd.
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Mindray
  • Zhejiang DIAN Diagnosis Co., Ltd. (DIAN Diagnosis)

第6章 中国体外診断試薬産業の将来発展

  • 発展動向
  • 機会
  • 市場規模拡大の予測

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Research and Forecast of China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2014-2018 mainly conducts in-depth analysis on the external environment, market operation, import & export of China's IVD reagent industry, and also summaries the latest development of key Chinese domestic enterprises in 2013, and finally forecasts the future industrial development. The information can offer investors the decisive reference for their investment in the field.

IVD reagent industry is an emerging industry in China, the start is late and the development is relatively backward compares with occidental countries. According to the data provided by IVD Special Committee, there are 300 to 400 IVD reagent manufacturing enterprises in China, of which, 200 enterprises own above designated scale. However, only about 20 enterprises have the ability to achieve annual sales income of more than CNY 100 million; most of enterprises are in small scale and the product variety is few.

In 2013, the market scale of China's IVD industry reached CNY 22.5 billion; among them, the market scale of IVD reagents was about CNY 16.3 billion.

The state policy encourages the competitive enterprises to strengthen their strength. In 2013, a series of policies which target to improve industry standard and threshold entered the substantive operation stage, which accelerates the elimination of small enterprises and improves the industry concentration ratio. Industrial consolidation is the development trend, and the enterprises with capital, technology and scale advantages will win gradually.

In recent years, due to the continued sluggishness of European and American pharmaceutical market, the international giants target on the market expansion brought by China's new medical reform, and entered China's market in succession; after the China-oriented R&D center transfer, these powerful enterprises began to compete with China's enterprises in the low and medium-end markets through mergers, acquisitions, capital increase and production expansion; therefore, the competitive enterprises in China's diagnostic reagent subdivided industries will face more sever competitions.

Table of Contents

1. Overview of Diagnostic Reagent Industry

  • 1.1. Definition and Classification
    • 1.1.1. Definition and Classification of Biological Products
    • 1.1.2. Definition and Classification of IVD Reagents
  • 1.2. Development History
  • 1.3. Industry Chain
  • 1.4. Overview of Main Sub-industries
    • 1.4.1. Biochemical Diagnostic Reagent Industry
    • 1.4.2. Immune Diagnostic Reagent Industry
    • 1.4.3. Molecular Diagnostic Reagent Industry

2. Operating Environment of China's IVD Reagent Industry

  • 2.1. Development Overview of Global IVD Reagent Industry
  • 2.2. Development Overview of China's Bio-pharmaceutical Industry
  • 2.3. National Related Industry Management and Policy
    • 2.3.1. Industry Competent Departments
    • 2.3.2. Industry Supervision System
    • 2.3.3. Main Laws and Regulations
    • 2.3.4. Main Industry Policies

3. Operation State of China's IVD Reagent Market

  • 3.1. Development Status
  • 3.2. Demand
    • 3.2.1. Overall Market Demand
    • 3.2.2. Application Status and Development Trend of Main Varieties
  • 3.3. Competitive Pattern
  • 3.4. Barriers to Entry
    • 3.4.1. Technology Barrier
    • 3.4.2. Quality and Brand Barrier
    • 3.4.3. Marketing Channel Barrier
    • 3.4.4. Market Access Barrier
  • 3.5. Profit Level and Variation Trend
  • 3.6. Adverse Factors for the Industry Development
    • 3.6.1. Low Market Concentration Ratio; Serious Product Homogeneity
    • 3.6.2. Relatively Low Overall R&D Investment Level
    • 3.6.3. International Giants Occupying Dominant Positions in China's High-end Market
  • 3.7. Technological Level and Business Model
    • 3.7.1. Technological Level and Development Trend
    • 3.7.2. Characteristics of Business Model
  • 3.8. Periodical, Regional and Seasonal Characteristics
    • 3.8.1. Periodicity
    • 3.8.2. Regional Nature
    • 3.8.3. Seasonality
  • 3.9. Relevance and Influence of Upstream Industries and Downstream Industries to the IVD Reagent Industry
    • 3.9.1. Upstream Raw Materials Mainly Depending on Imports
    • 3.9.2. Downstream Demands Showing the Rigidity
    • 3.9.3. Relevance with the IVD Instrument Industry

4. Import and Export of China's IVD Reagent Industry

  • 4.1. Import
  • 4.2. Export

5. China's Key IVD Reagent Enterprises

  • 5.1. Shanghai Kehua Bio-engineering Co., Ltd.
    • 5.1.1. Company Profile
    • 5.1.2. Operating Conditions
    • 5.1.3. Core Competitiveness
    • 5.1.4. R & D Project, Business Plan and Future Development Strategy, 2013
  • 5.2. DAAN Gene Co., Ltd.
    • 5.2.1. Company Profile
    • 5.2.2. Business Development
    • 5.2.3. Main Business Composition
    • 5.2.4. Core Competitiveness
    • 5.2.5. Acquiring the Official Approval of Ministry of Finance, Equity Incentive Plan Getting Great Progress
  • 5.3. Shanghai Fosun Pharmaceutical (Group) CO., Ltd.
    • 5.3.1. Company Profile
    • 5.3.2. Main Business Composition
    • 5.3.3. Development of Medical Diagnosis and Medical Device Business
  • 5.4. BioSino Bio-technology and Science Inc.
    • 5.4.1. Company Profile
    • 5.4.2. Operating Conditions
    • 5.4.3. Future Development Strategy
  • 5.5. Beijing Leadman Biochemistry Co., Ltd.
    • 5.5.1. Company Profile
    • 5.5.2. Operating Conditions
    • 5.5.3. Main Business Composition
  • 5.6. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
    • 5.6.1. Company Profile
    • 5.6.2. Operating Conditions
    • 5.6.3. Products
  • 5.7. Mindray
    • 5.7.1. Company Profile
    • 5.7.2. Operating Conditions
    • 5.7.3. Business Development
  • 5.8. Zhejiang DIAN Diagnosis Co., Ltd. (DIAN Diagnosis)
    • 5.8.1. Company Profile
    • 5.8.2. Business Development
    • 5.8.3. Main Business Composition

6. Future Development of China's IVD Reagent Industry

  • 6.1. Development Trends
  • 6.2. Opportunities
  • 6.3. Growth Forecast of Market Scale, 2014-2018
Back to Top